Annual Accounts Payable
$4.76 M
-$3.61 M-43.11%
01 December 2023
Summary:
Plus Therapeutics annual accounts payable is currently $4.76 million, with the most recent change of -$3.61 million (-43.11%) on 01 December 2023. During the last 3 years, it has risen by +$3.97 million (+503.04%). PSTV annual accounts payable is now -43.11% below its all-time high of $8.36 million, reached on 31 December 2022.PSTV Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
N/A
01 September 2024
Summary:
Plus Therapeutics quarterly accounts payable is not available.PSTV Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PSTV Accounts Payable Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | - | - |
3 y3 years | +503.0% | - |
5 y5 years | +559.9% | - |
PSTV Accounts Payable High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -43.1% | +503.0% | ||
5 y | 5 years | -43.1% | +1355.0% | ||
alltime | all time | -43.1% | +1649.3% |
Plus Therapeutics Accounts Payable History
Date | Annual | Quarterly |
---|---|---|
Dec 2023 | $4.76 M(-43.1%) | $4.76 M(-43.1%) |
Dec 2022 | $8.36 M(+220.3%) | $8.36 M(+220.3%) |
Dec 2021 | $2.61 M(+230.9%) | $2.61 M(+230.9%) |
Dec 2020 | $789.00 K(+141.3%) | $789.00 K(+141.3%) |
Dec 2019 | $327.00 K(-54.6%) | $327.00 K(-54.6%) |
Dec 2018 | $721.00 K(-44.4%) | $721.00 K(-44.4%) |
Dec 2017 | $1.30 M(-2.6%) | $1.30 M(-2.6%) |
Dec 2016 | $1.33 M(+32.0%) | $1.33 M(+32.0%) |
Dec 2015 | $1.01 M(+6.3%) | $1.01 M(+6.3%) |
Dec 2014 | $949.00 K(-1.7%) | $949.00 K(-1.7%) |
Dec 2013 | $965.00 K(-38.9%) | $965.00 K(-38.9%) |
Dec 2012 | $1.58 M(+480.5%) | $1.58 M(+480.5%) |
Dec 2011 | $272.00 K(-41.4%) | $272.00 K(-41.4%) |
Dec 2008 | $464.00 K | $464.00 K(-93.0%) |
Sept 2008 | - | $6.63 M(-3.1%) |
Date | Annual | Quarterly |
---|---|---|
June 2008 | - | $6.84 M(+1.9%) |
Mar 2008 | - | $6.71 M(+1300.2%) |
Dec 2007 | $479.00 K(-34.3%) | $479.00 K(-90.2%) |
Sept 2007 | - | $4.90 M(+1.5%) |
June 2007 | - | $4.83 M(-4.6%) |
Mar 2007 | - | $5.06 M(+594.0%) |
Dec 2006 | $729.00 K(-88.1%) | $729.00 K(+103.1%) |
Sept 2006 | - | $359.00 K(-91.6%) |
June 2006 | - | $4.27 M(-22.7%) |
Mar 2006 | - | $5.52 M(-9.9%) |
Dec 2005 | $6.13 M(+163.2%) | $6.13 M(+1045.6%) |
Sept 2005 | - | $535.00 K(-78.5%) |
June 2005 | - | $2.49 M(+4.6%) |
Mar 2005 | - | $2.38 M(+2.1%) |
Dec 2004 | $2.33 M | $2.33 M |
FAQ
- What is Plus Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Plus Therapeutics?
- What is the all time high quarterly accounts payable for Plus Therapeutics?
What is Plus Therapeutics annual accounts payable?
The current annual accounts payable of PSTV is $4.76 M
What is the all time high annual accounts payable for Plus Therapeutics?
Plus Therapeutics all-time high annual accounts payable is $8.36 M
What is the all time high quarterly accounts payable for Plus Therapeutics?
Plus Therapeutics all-time high quarterly accounts payable is $8.36 M